Pembrolizumab
Immunotherapy for many cancers — the world's top-selling medicine.
- Starts working
- Varies
- Half-life
- About 22 days
- In use since
- 2014
- Pregnancy
- Usually avoided
Overview
Pembrolizumab (Keytruda) releases a brake on the immune system so it can attack cancer. It's approved for melanoma, lung, kidney, bladder, head and neck, cervical and many other cancers. Side effects come from immune attacks on normal organs and can appear months later.
Conditions it's used for
How it works
Takes the brakes off your immune cells so they can find and kill cancer.
Pembrolizumab belongs to the Immune checkpoint inhibitors. How Immune checkpoint inhibitors work: remove a brake cancer cells use to hide from T-cells, so the immune system attacks the tumour. Side effects come from the immune system attacking healthy organs.
Uses
- Melanoma
- Non-small cell lung cancer
- Kidney, bladder, head and neck cancers
- Triple-negative breast cancer
- Cervical and endometrial cancer
- MSI-high tumours
- Kidney cancer
Available as: iv infusion, subcutaneous injection.
Typical dose
- Adults
- 200 mg every 3 weeks or 400 mg every 6 weeks IV.
Typical doses for orientation only. Your prescription, the pack leaflet and local guidance take priority.
Side effects
Common
Often mild and may settle with time
- Tiredness
- Rash and itch
- Diarrhoea
- Underactive thyroid
Serious — get medical help
Uncommon, but need prompt attention
- Pneumonitis
- Colitis
- Hepatitis
- Type 1 diabetes
- Myocarditis
- Adrenal or pituitary failure
Warnings
- Report any new symptom — early steroids treat immune side effects
- Carry an immunotherapy alert card
Interactions
- Steroids and immunosuppressants — may blunt effect if used before starting
Pregnancy and breastfeeding
Usually avoided
Contraception needed.
Breastfeeding advice can differ from pregnancy advice — check with a pharmacist, or the LactMed database.
Brand names
- United States
- Keytruda, Keytruda Qlex
- United Kingdom
- Keytruda
- India
- Keytruda
- Australia
- Keytruda
Examples only; many generic versions exist. The same brand name can mean different products in different countries.
History
Former US President Jimmy Carter's melanoma, which had spread to his brain, responded to pembrolizumab in 2015.
A subcutaneous version was approved in the US in 2025.
Common questions
How is it different from chemotherapy?
It doesn't attack cancer directly; it lets your immune system do it, so responses can be long-lasting.
Do I need a prescription for Pembrolizumab?
Yes — Pembrolizumab is prescription-only in most countries.
Can I take Pembrolizumab during pregnancy?
Usually avoided. Contraception needed. Always check with a doctor or midwife.
Related medicines
Nivolumab
PD-1 immunotherapy, often combined with ipilimumab.
RxImmune checkpoint inhibitorsOsimertinib
Targeted pill for EGFR-mutated lung cancer.
RxTyrosine kinase inhibitorsBevacizumab
Cuts off a tumour's blood supply.
RxTargeted antibodiesCisplatin
Platinum chemotherapy that made testicular cancer curable.
RxWHOPlatinum chemotherapyAtezolizumab
PD-L1 checkpoint inhibitor given by infusion.
RxImmune checkpoint inhibitors
Sources and official information
- MedlinePlus (US National Library of Medicine)
- DailyMed — official US labels
- NHS medicines A–Z
- WHO ATC/DDD index — L01FF02
- WHO Model List of Essential Medicines
Entry last reviewed October 2026. Compiled from WHO, NHS, FDA/DailyMed, BNF and national formulary information. How we write entries.